Lee Danner & Bass Inc Eli Lilly & CO Transaction History
Lee Danner & Bass Inc
- $1.17 Billion
- Q4 2023
A detailed history of Lee Danner & Bass Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Lee Danner & Bass Inc holds 494 shares of LLY stock, worth $464,251. This represents 0.02% of its overall portfolio holdings.
Number of Shares
494
Previous 483
2.28%
Holding current value
$464,251
Previous $259,000
11.2%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
3,728Shares Held
738MCall Options Held
7.09MPut Options Held
7.24M-
Lilly Endowment Inc Indianapolis, IN98.9MShares$92.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$68.4 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$61.3 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$48.3 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$32.2 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $893B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...